Identification of an HLA-A*0201-restricted CD8+ T-cell epitope encoded within Leptospiral immunoglobulin-like protein A

Microbes and Infection

Volumn 12, Issue 5, 2010, Pages 364-373

  Guo, Ying Jun ^a   Wang, Kai Yu ^a   Sun, Shu Han ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

HLA A0201 antigen; Leptospirosis; T cell epitope; Transgenic mice; Vaccine

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; IMMUNOGLOBULIN A; LEPTOSPIRAL IMMUNOGLOBULIN LIKE PROTEIN A; TETRAMER; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; HLA A*0201 ANTIGEN; HLA-A*0201 ANTIGEN; LIGA M PROTEIN, LEPTOSPIRA INTERROGANS; LIGA-M PROTEIN, LEPTOSPIRA INTERROGANS;

ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNOGENICITY; LEPTOSPIRA; LEPTOSPIROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE IMMUNITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STABILITY; TRANSGENIC MOUSE; ANIMAL; EPITOPE MAPPING; IMMUNOLOGY; METABOLISM; MOUSE;

LEPTOSPIRA; LIGA; MUS MUSCULUS;

ANIMALS; ANTIGENS, BACTERIAL; CD8-POSITIVE T-LYMPHOCYTES; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMANS; LEPTOSPIRA; LEPTOSPIROSIS; MICE; MICE, TRANSGENIC; PROTEIN BINDING;

EID: 77950845913     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.01.010     Document Type: Article

References (41)

1. Faine S.B., Adher B., Bolin C., and Perolat P. Leptospira and Leptospirosis. second ed. (1999), MedSci, Medbourne, Australia
2. Bharti A.R., Nally J.E., Ricaldi J.N., Matthias M.A., Diaz M.M., Lovett M.A., Levett P.N., Gilman R.H., Willig M.R., Gotuzzo E., and Vinetz J.M. Peru-United States Leptospirosis Consortium. Lancet. Infect. Dis. 3 (2003) 757-771
3. Brown R.A., Blumerman S., Gay C., Bolin C., Duby R., and Baldwin C.L. Comparison of three different leptospiral vaccines for induction of a type 1 immune response to Leptospira borgpetersenii serovar Hardjo. Vaccine 21 (2003) 4448-4458
4. Naiman B.M., Blumerman S., Alt D., Bolin C.A., Brown R., Zuerner R., and Baldwin C.L. Evaluation of type 1 immune response in naïve and vaccinated animals following challenge with Leptospira borgpetersenii serovar Hardjo: involvement of WC1(+) gammadelta and CD4 T cells. Infect. Immun. 70 (2002) 6147-6157
5. Kägi D., Vignaux F., Ledermann B., Bürki K., Depraetere V., Nagata S., Hengartner H., and Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265 (1994) 528-530
6. Lowin B., Hahne M., Mattmann C., and Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370 (1994) 650-652
7. Li L., Ojcius D.M., and Yan J. Comparison of invasion of fibroblasts and macrophages by high- and low-virulence Leptospira strains: colonization of the host-cell nucleus and induction of necrosis by the virulent strain. Arch. Microbiol. 188 (2007) 591-598
8. Merien F., Baranton G., and Perolat P. Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence. Infect. Immun. 65 (1997) 729-738
9. van Voorhis W.C., Barrett L.K., Nasio J.M., Plummer F.A., and Lukehart S.A. Lesions of primary and secondary syphilis contain activated cytolytic T cells. Infect. Immun. 64 (1996) 1048-1050
10. Busch D.H., Jassoy C., Brinckmann U., Girschick H., and Huppertz H.I. Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T cells in patients with Lyme arthritis. J. Immunol. 157 (1996) 3534-3541
11. Pereira M.M., Andrade J., Marchevsky R.S., and Ribeiro dos Santos R. Morphological characterization of lung and kidney lesions in C3H/HeJ mice infected with Leptospira interrogans serovar icterohaemorrhagiae: defect of CD4+ and CD8 + T-cells are prognosticators of the disease progression. Exp. Toxicol. Pathol. 50 (1998) 191-198
12. Gallimore A., Glithero A., Godkin A., Tissot A.C., Plückthun A., Elliott T., Hengartner H., and Zinkernagel R. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187 (1998) 1383-1393
13. Yee C., Riddell S.R., and Greenberg P.D. Prospects for adoptive T cell therapy. Curr. Opin. Immunol. 9 (1997) 702-708
14. Shieh D.C., Lin D.T., Yang B.S., Kuan H.L., and Kao K.J. High frequency of HLA-A*0207 subtype in Chinese population. Transfusion 36 (1996) 818-821
15. Pascolo S. HLA class I transgenic mice: development, utilisation and improvement. Expert. Opin. Biol. Ther. 5 (2005) 919-938
16. Faine S. Guidelines for the control of leptospirosis. WHO Offset. Publ. 67 (1982) 1-171
17. Parham P., and Brodsky F.M. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol. 3 (1981) 277-299
18. Wang K.Y., Guo Y.J., Zhang Y.L., Lv K., and Sun S.H. Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice. Vaccine 25 (2007) 4429-4436
19. Li D.A., He Y., Guo Y.J., Wang F., Song S.X., Wang Y., Yang F., He X.W., and Sun S.H. Comparative proteomics analysis to annexin B1 DNA and protein vaccination in mice. Vaccine 25 (2007) 932-938
20. Zhang S., Guo Y.J., Sun S.H., Wang K.Y., Wang K.H., Zhang Y., Zhu W.J., Chen Z.H., and Jiang L. DNA vaccination using bacillus Calmette-Guerin-DNA as an adjuvant to enhance immune response to three kinds of swine diseases. Scand. J. Immunol. 62 (2005) 371-377
21. Song S., Wang F., He X., He Y., Li D., and Sun S. Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice. Vaccine 25 (2007) 4853-4860
22. Ren D., Wang F., He X., Jiang L., Li D., Ying H., and Sun S. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli. Protein. Expr. Purif. 50 (2006) 171-178
23. Sable S.B., Kalra M., Verma I., and Khuller G.K. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity. Clin. Immunol. 122 (2007) 239-251
24. Nussbaum A.K., Kuttler C., Tenzer S., and Schild H. Using the World Wide Web for predicting CTL epitopes. Curr. Opin. Immunol. 15 (2003) 69-74
25. Matsunaga J., Sanchez Y., Xu X., and Haake D.A. Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA. Infect. Immun. 73 (2005) 70-78
26. Groothuis T.A., and Neefjes J. The many roads to cross-presentation. J. Exp. Med. 202 (2005) 1313-1318
27. Kessler J.H., Beekman N.J., Bres-Vloemans S.A., Verdijk P., van Veelen P.A., Kloosterman-Joosten A.M., Vissers D.C., ten Bosch G.J., Kester M.G., Sijts A., Wouter Drijfhout J., Ossendorp F., Offringa R., and Melief C.J. Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J. Exp. Med. 193 (2001) 73-88
28. Ayyoub M., Stevanovic S., Sahin U., Guillaume P., Servis C., Rimoldi D., Valmori D., Romero P., Cerottini J.C., Rammensee H.G., Pfreundschuh M., Speiser D., and Lévy F. Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma. J. Immunol. 168 (2002) 1717-1722
29. Yee C., Savage P.A., Lee P.P., Davis M.M., and Greenberg P.D. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol. 162 (1999) 2227-2234
30. Lucas M., Vargas-Cuero A.L., Lauer G.M., Barnes E., Willberg C.B., Semmo N., Walker B.D., Phillips R., and Klenerman P. Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8 + T cells. J. Immunol. 172 (2004) 1744-1753
31. Ford M.L., and Evavold B.D. Specificity, magnitude, and kinetics of MOG-specific CD8 + T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 35 (2005) 76-85
32. Choy H.A., Kelley M.M., Chen T.L., Moller A.K., Matsunaga J., and Haake D.A. Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect. Immun. 75 (2007) 2441-2450
33. Palaniappan R.U., McDonough S.P., Divers T.J., Chen C.S., Pan M.J., Matsumoto M., and Chang Y.F. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect. Immun. 74 (2006) 1745-1750
34. Silva E.F., Medeiros M.A., McBride A.J., Matsunaga J., Esteves G.S., Ramos J.G., Santos C.S., Croda J., Homma A., Dellagostin O.A., Haake D.A., Reis M.G., and Ko A.I. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25 (2007) 6277-6286
35. Koizumi N., and Watanabe H. Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22 (2004) 1545-1552
36. Jauréguiberry S., Roussel M., Brinchault-Rabin G., Gacouin A., Le Meur A., Arvieux C., Michelet C., and Tattevin P. Clinical presentation of leptospirosis: a retrospective study of 34 patients admitted to a single institution in metropolitan France. Clin. Microbiol. Infect. 11 (2005) 391-394
37. Lopes A.A., Costa E., and Sacramento E. Lymphopenia in hospitalised cases of leptospirosis. Clin. Microbiol. Infect. 11 (2005) 857-858
38. Werts C., Tapping R.I., Mathison J.C., Chuang T.H., Kravchenko V., Saint Girons I., Haake D.A., Godowski P.J., Hayashi F., Ozinsky A., Underhill D.M., Kirschning C.J., Wagner H., Aderem A., Tobias P.S., and Ulevitch R.J. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2 (2001) 346-352
39. Isogai E., Isogai H., Kubota T., Fujii N., Hayashi S., Indoh T., Takagi S., Miura H., and Kimura K. Apoptosis of lymphocytes in mice administered lipopolysaccharide from Leptospira interrogans. Zentralbl. Veterinarmed. B. 45 (1998) 529-537
40. De Brito T., Menezes L.F., Lima D.M., Lourenco S., Silva A.M., and Alves V.A. Immunohistochemical and in situ hybridization studies of the liver and kidney in human leptospirosis. Virchows. Arch. 448 (2006) 576-583
41. Dolhnikoff M., Mauad T., Bethlem E.P., and Carvalho C.R. Pathology and pathophysiology of pulmonary manifestations in leptospirosis. Braz. J. Infect. Dis. 11 (2007) 142-148